Navigation Links
CareFusion Announces $500 Million Share Repurchase Program

SAN DIEGO, Feb. 10, 2012 /PRNewswire/ -- CareFusion Corp. (NYSE: CFN), a leading, global medical technology company, today announced that its board of directors authorized the repurchase of up to $500 million of the company's common stock.


"This share repurchase program reflects our confidence in CareFusion's growth potential and our commitment to increasing shareholder value," said Kieran Gallahue, chairman and CEO. "With our strong balance sheet and cash flow generation, we also remain committed to making disciplined, strategic investments for growth that will maximize value for our shareholders over the long term." 

The program authorizes the company to repurchase shares of its common stock through open market and private transactions. The size and timing of any purchases are at the discretion of management, based on factors such as price, business and market conditions. The share repurchase program is expected to continue through December 2013.

This is the first share repurchase program for CareFusion, which spun off from Cardinal Health and began operating as a separate publicly traded company in September 2009. The company had approximately 227 million shares of common stock outstanding as of Dec. 31, 2011.

About CareFusion Corporation

CareFusion (NYSE: CFN) is a global corporation serving the health care industry with products and services that help hospitals measurably improve the safety and quality of care. The company develops market-leading technologies including Alaris® infusion pumps, Pyxis® automated dispensing and patient identification systems, AVEA®, AirLife™ and LTV® series ventilation and respiratory products, ChloraPrep® products, MedMined® services for data mining surveillance, Nicolet™ neurological monitoring and diagnostic products, V. Mueller® surgical instruments, and an extensive line of products that support interventional medicine. CareFusion employs more than 14,000 people across its global operations. More information may be found at

Cautions Concerning Forward-looking Statements

The CareFusion news release and the information contained herein contains forward-looking statements addressing expectations, prospects, estimates and other matters that are dependent upon future events or developments. The matters discussed in these forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected, anticipated or implied. Forward-looking statements include, but are not limited to, statements about CareFusion's intention to repurchase shares of its common stock, including the amount and timing of its repurchase program.  The forward-looking statements contained herein are based on the current expectations and assumptions of CareFusion and not on historical facts.  The following important factors, among others, could cause actual results to differ materially from those set forth in the forward looking statements:  uncertainties as to the market price of CareFusion's common stock, market conditions in general and CareFusion's future operating performance.  Additional factors that may affect future results are described in CareFusion's Form 10-K, Form 10-Q and Form 8-K reports (including all amendments to those reports) and exhibits to those reports that it files with the U.S. Securities and Exchange Commission. Except to the limited extent required by applicable law, CareFusion undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

SOURCE CareFusion Corp.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. CareFusion Reports Second Quarter Fiscal 2012 Results
2. CareFusion Provides Update on Voluntary Recall of Neurological Monitoring Software and Devices
3. CareFusion Receives Federal Data Encryption Certification for Alaris® Infusion System
4. CareFusion Announces Preliminary Second Quarter Results
5. CareFusion Provides Update on Previously Announced Ventilator Recall
6. CareFusion Showcases Medication Management Technologies at American Society for Health-System Pharmacists Conference
7. CareFusion Launches Wireless Diagnostic and Monitoring Neurological Device
8. CareFusion Announces New Ventilation Solution to Help Hospitals Provide Improved Patient Care and Reduce Costs
9. CareFusion Initiates Class I Recall of EnVe Ventilators
10. CareFusion Launches New Emergency Transport Ventilator
11. B. Braun Medical Sues CareFusion for Patent Infringement
Post Your Comments:
(Date:11/24/2015)... , 24. November 2015 ... Breathing Pacemaker Systems, ist erfreut, die Berufung ... Consultant bekannt geben zu können. ...   --> Foto - ... (Schweden). Von 1984-1986 war er Fellow ...
(Date:11/24/2015)... Avery Biomedical Devices (ABD), manufacturer of the ... appointment of Anders Jonzon , MD; Ph.D. as ... Dr. Jonzon is a Physiologist and consultant ... University, Uppsala and Children,s Hospital, Karolinska, Stockholm, ... at the Cardiovascular Institute (UCSF). His research has covered ...
(Date:11/24/2015)... Inc. (Pink Sheets: ASDS ) ("Ascendant" or the "Company") ... special 1 percent stock dividend on the company,s common stock ... shareholders of record December 7, 2015.  The dividend will be ... --> --> "This ... confidence in Ascendant,s growth strategy as well as the underlying ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... , ... In an ongoing Clinical Study conducted by an independent physician, Andrew ... is evaluating the efficacy of its product and its disinfection protocol. This study is ... May 2014 through October 2015 at a 360-bed, acute-care, academic medical center located in ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... found that regular bras were incredibly uncomfortable," said an inventor from Bronx, N.Y. ... , She developed the patent-pending RECOVERY BRA for added comfort and support. The ...
(Date:11/25/2015)... ... November 25, 2015 , ... Since its launch in ... involving adult stem cell therapies to patients with chronic degenerative medical conditions. Now, ... a Registered Trademark (RTM). , Organizations are required to hold a registered trademark ...
(Date:11/24/2015)... ... November 24, 2015 , ... Dr. Todd S. Afferica, a noted general ... many of his patients. Dr. Afferica now uses the BIOLASE WaterLase iPlus 2.0™ in ... time the doctor uses other traditional cutting tools, such as the scalpel and high-speed ...
(Date:11/24/2015)... ... 2015 , ... In an article published November 12th by Obesity ... are or are not eligible for bariatric surgery. The article explains that candidates for ... than 100 pounds overweight, or have a BMI of 35 and over with at ...
Breaking Medicine News(10 mins):